Geneology International

Tag: gestational

  • The effect of prophylactic chemotherapy on treatment outcome of postmolar gestational trophoblastic neoplasia | BMC Women’s Health

    The effect of prophylactic chemotherapy on treatment outcome of postmolar gestational trophoblastic neoplasia | BMC Women’s Health

  • Ngan HYS, Seckl MJ, Berkowitz RS, Xiang Y, Golfier F, Sekharan PK, et al. Diagnosis and management of gestational trophoblastic disease: 2021 update. Int J Gynaecol Obstet. 2021;155(Suppl 1):86–93.

    Article 

    Google Scholar     

  • Berkowitz RS, Goldstein DP. Chorionic tumors. N Engl J Med. 1996;335:1740–8.

    Article 

    Google Scholar     

  • Ngan HY, Kohorn EI, Cole LA, Kurman RJ, Kim SJ, Lurain JR, et al. Trophoblastic disease. Int J Gynaecol Obstet. 2012;119(Suppl 2):130–6.

    Article 

    Google Scholar     

  • Rice LW, Berkowitz RS, Lage JM, Goldstein DP, Bernstein MR. Persistent gestational trophoblastic tumor after partial hydatidiform mole. Gynecol Oncol. 1990;36:358–62.

    Article 

    Google Scholar     

  • Feltmate CM, Growdon WB, Wolfberg AJ, Goldstein DP, Genest DR, Chinchilla ME, et al. Clinical characteristics of persistent gestational trophoblastic neoplasia after partial hydatidiform molar pregnancy. J Reprod Med. 2006;51:902–6.


    Google Scholar     

  • Hancock BW, Nazir K, Everard JE. Persistent gestational trophoblastic neoplasia after partial hydatidiform mole: incidence and outcome. J Reprod Med. 2006;51:764–6.


    Google Scholar     

  • Abu-Rustum NR, Yashar CM, Bean S, Bradley K, Campos SM, Chon HS, et al. Gestational trophoblastic neoplasia, version 2.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Comper Canc Netw. 2019;17:1374–91.

    Article 

    Google Scholar     

  • Goldstein DP, Berkowitz RS, Bernstein MR. Management of molar pregnancy. J Reprod Med. 1981;26:208–12.


    Google Scholar     

  • Limpongsanurak S. Prophylactic actinomycin D for high-risk complete hydatidiform mole. J Reprod Med. 2001;46:110–6.


    Google Scholar     

  • Uberti EM, Fajardo MC, Da Cunha AG, Ayub AC, Graudenz MS, Schmid H. Gestational trophoblastic neoplasia using prophylactic single bolus dose of actinomycin D in high-risk hydatidiform mole: a simple, effective, secure and low-cost approach without adverse effects on compliance to general follow-up or subsequent treatment. Gynecol Oncol. 2009;114:299–305.

    Article 

    Google Scholar     

  • Lewis JL, Gore H, Hertig AT, Goss DA. Treatment of trophoblastic neoplasms. With rationale for the use of adjunctive chemotherapy at the time of indicated operation. Am J Obstet Gynecol. 1966;96:710–22.

    Article 

    Google Scholar     

  • Wang Q, Fu J, Hu L, Fang F, Xie L, Chen H, et al. Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasia. Cochrane Database Syst Rev. 2017;9:CD007289.


    Google Scholar     

  • Goldstein DP, Berkowitz RS. Prophylactic chemotherapy of complete molar pregnancy. Semin Oncol. 1995;22:157–60.


    Google Scholar     

  • Hancock BW. Difference in management and treatment: a critical appraisal. In: Hancock BW, Seckl MJ, Berkowitz RS, Cole LA, editors. Gestational trophoblastic disease. 3rd ed. London: Chapman & Hall Medical; 2009. p. 447–59.


    Google Scholar     

  • Kim DS, Moon H, Kim KT, Moon YJ, Hwang YY. Effects of prophylactic chemotherapy for persistent trophoblastic disease in patients with complete hydatidiform mole. Obstet Gynecol. 1986;67:690–4.

    Article 

    Google Scholar     

  • Seckl M. Time to stop offering prophylactic chemotherapy after molar pregnancies? BJOG. 2014;121:1420.


    Google Scholar     

  • Soares PD, Maesta I, Costa OL, Charry RC, Dias A, Rudge MV. Geographical distribution and demographic characteristics of gestational trophoblastic disease. J Reprod Med. 2010;55:305–10.


    Google Scholar     

  • Mangili G, Lorusso D, Brown J, Pfisterer J, Massuger L, Vaughan M, et al. Trophoblastic disease review for diagnosis and management: a joint report from the International Society for the Study of Trophoblastic Disease, European Organisation for the Treatment of Trophoblastic Disease, and the Gynecologic Cancer Inter Group. Int J Gynecol Cancer. 2014;24:S109-116.

    Article 

    Google Scholar     

  • Charry RC. Presentation and management of molar pregnancy and gestational trophoblastic neoplasia in Latin America. In: Hancock BW, Seckl MJ, Berkowitz RS, Cole LA, editors. Gestational trophoblastic disease. 3rd ed. London: Chapman & Hall Medical; 2009. p. 407–19.


    Google Scholar     

  • Xiang Y, Qi Z, Xiaohua W, Jihong L, Li L, Miqing Z, et al. Guidelines for the diagnosis and treatment of geatational trophoblastic disease (4th ed). Chin J Pract Gynecol Obstet. 2018;34:994–1001 (in Chinese).


    Google Scholar     

  • Braga A, Moraes V, Maestá I, Amim Júnior J, Rezende-Filho Jd, Elias K, et al. Changing trends in the clinical presentation and management of complete hydatidiform mole among Brazilian women. Int J Gynecol Cancer. 2016;26:984–90.

    Article 

    Google Scholar     

  • Lybol C, Sweep FC, Ottevanger PB, Massuger LF, Thomas CM. Linear regression of postevacuation serum human chorionic gonadotropin concentrations predicts postmolar gestational trophoblastic neoplasia. Int J Gynecol Cancer. 2013;23:1150–6.

    Article 

    Google Scholar     

  • Kerkmeijer LG, Massuger LF, Ten Kate-Booij MJ, Sweep FC, Thomas CM. Earlier diagnosis and serum human chorionic gonadotropin regression in complete hydatidiform moles. Obstet Gynecol. 2009;113:326–31.

    Article 

    Google Scholar     

  • Kaneki E, Kobayashi H, Hirakawa T, Matsuda T, Kato H, Wake N. Incidence of postmolar gestational trophoblastic disease in androgenetic moles and the morphological features associated with low risk postmolar gestational trophoblastic disease. Cancer Sci. 2010;101:1717–21.

    Article 

    Google Scholar     

  • Ngan HYBH, Benedet JL, Jones H, Montruccoli GC, Pecorelli S, FIGO Committee on Gynecologic Oncology. Gestational trophoblastic neoplasia, FIGO 2000 staging and classification. Int J Gynecol Cancer. 2003;83(Suppl 1):175–7.

    Article 

    Google Scholar     

  • Elias KM, Shoni M, Bernstein M, Goldstein DP, Berkowitz RS. Complete hydatidiform mole in women aged 40–49 years. J Reprod Med. 2012;57:254–8.


    Google Scholar     

  • Kashimura Y, Kashmira M, Sugimori H, Tsukamoto N, Matsuyama T, Matsukuma K, et al. Prophylactic chemotherapy for hydatidiform mole: 5–15 years follow-up. Cancer. 1986;58:624–9.

    Article 

    Google Scholar     

  • Park TK, Kim SN, Lee SK. Analysis of risk factors for postmolar trophoblastic disease: categorization of risk factors and effect of prophylactic chemotherapy. Yonsei Med J. 1966;37:412–9.

    Article 

    Google Scholar     

  • Fasoli M, Ratti F, Francheschi S, La Vecchia C, Pecorelli S, Mangioni C. Management of gestational trophoblastic disease: results of a cooperative study. Obstet Gynecol. 1982;60:205–9.


    Google Scholar     

  • Goldstein DP. Prevention of gestational trophoblastic disease by use of actinomycin D in molar pregnancies. Obstet Gynecol. 1974;43:475–9.


    Google Scholar     

  • Goldstein DP. Prophylactic chemotherapy of patients with molar pregnancy. Obstet Gynecol. 1971;38:817–22.


    Google Scholar     

  • Uberti EM, Diestel MC, Guimarães FE, De Nápoli G, Schmid H. Single-dose actinomycin D: efficacy in the prophylaxis of post molar gestational trophoblastic neoplasia in adolescents with high-risk hydatidiform mole. Gynecol Oncol. 2006;102:325–32.

    Article 

    Google Scholar     

  • Fowler DJ, Lindsay I, Seckl MJ, Sebire NJ. Routine preevacuation ultrasound diagnosis of hydatidiform mole: experience of more than 1000 cases from a regional referral center. Ultrasound Obst Gyn. 2006;27:56–60.

    Article 

    Google Scholar     

  • Koga K, Maeda K. Prophylactic chemotherapy with Amethopterin for prevention of choriocarcinoma following removal of hydatidiform mole. Am J Obstet Gynecol. 1968;100:270–5.

    Article 

    Google Scholar     

  • Yamamoto E, Trinh TD, Sekiya Y, Tamakoshi K, Nguyen XP, Nishino K, et al. The management of hydatidiform mole using prophylactic chemotherapy and hysterectomy for high-risk patients decreased the incidence of gestational trophoblastic neoplasia in Vietnam: a retrospective observational study. Nagoya J Med Sci. 2020;82:183–91.


    Google Scholar     

  • Healthy Lifestyle Helps Prevent Gestational Diabetes in Individuals at Highest Risk

    Healthy Lifestyle Helps Prevent Gestational Diabetes in Individuals at Highest Risk

    Investigators acquire a genetic-hazard score to determine these who would benefit most from life-style counseling to protect against the issue.

    Investigators from the University of Helsinki have designed a genetic-hazard score for pinpointing individuals who would profit the most from life-style counseling to avert gestational and postpartum diabetic issues.

    Gestational diabetes has a substantial affect on the health and fitness of the mom and little one through pregnancy, as very well as right after delivery and is 1 of the most widespread health and fitness-linked worries for the duration of pregnancy, according to a statement.

    Investigators examined the effects of life-style intervention on the prevention of gestational diabetic issues in women at substantial danger of developing the issue. They also observed that prediabetes and diabetic issues 1 12 months right after supply had been also additional widespread between those with higher scores.

    In the End Gestational Diabetic issues Avoidance Examine, recognised as RADIEL, persons who were included gained intensified dieting counseling and actual physical workout in the course of pregnancy and for the to start with calendar year immediately after supply.

    In the study, a polygenic hazard score (PRS) describing the genetic threat of diabetes was calculated making use of gene variants regarded to increase the chance of kind 2 diabetic issues (T2D). The risk rating for T2D was involved with elevated glucose levels in mid and late pregnancy and for the very first calendar year soon after supply.

    Investigators also discovered that the genetic hazard also impacted the link amongst lifestyle counseling and gestational diabetes as properly as diabetes.

    “Based on our analysis, intensified way of life interventions benefited only gals at optimum genetic threat of establishing style 2 diabetic issues,” Emilia Huvinen, a professional in obstetrics and gynecology, said in the assertion. “Our research delivers 1 probable clarification for the contradictory outcomes of earlier scientific studies investigating the avoidance of gestational diabetes till now.”

    The genetic possibility scoring would enable discover expectant moms who were most at risk and also direct them to the most helpful preventive actions and assets, according to investigators.

    The analyze benefits are not only considerable but globally one of a kind as effectively, Huvinen explained.

    RADIEL was performed amongst 2008 and 2013 in Helsinki and Lappeenranta in Finland and integrated men and women who had a superior possibility of diabetic issues all through being pregnant, all those who ended up currently overweight early in pregnancy, or females who had a background of gestational diabetes.

    A whole of 724 ladies were randomized to a control team or underwent the intensified nutritional interventions and bodily exercise 3 times through pregnancy and 3 situations in the to start with year right after delivery.

    The dietary assistance adhered to the Nordic nutritional suggestions, with a overall of 150 minutes of moderately intense physical exercise per 7 days advised.

    The PRS rating for the genetic chance of diabetic issues was calculated applying 50 regarded hazard variants that are connected with T2D.

    “It’s critical to understand that, in the scenario of diabetic issues, our genetic background does not decide our long term. With the enable of a healthful lifestyle, you can reverse the result of a high genetic diabetic issues risk,” Huvinen claimed.

    Reference

    A healthier life style aids to prevent gestational diabetes in those at greatest genetic possibility. EurekAlert. Information release. May well 4, 2022. Accessed Could 4, 2022. https://www.eurekalert.org/information-releases/951643

  • A healthy lifestyle helps to prevent gestational diabetes in those at highest genetic risk — ScienceDaily

    A healthy lifestyle helps to prevent gestational diabetes in those at highest genetic risk — ScienceDaily

    Researchers have designed a genetic-threat score for pinpointing individuals who would reward the most from life-style counselling to prevent gestational and postpartum diabetic issues.

    Gestational diabetes is the most popular overall health-similar challenge for the duration of being pregnant. Right now, it is diagnosed in just about every fifth expectant mom in Finland. Gestational diabetes has a sizeable impression on the well being of both the mother and the baby, each throughout being pregnant and just after shipping and delivery.

    A analyze executed at the College of Helsinki investigated the consequences of way of life intervention on the avoidance of gestational diabetes in ladies at high danger of acquiring gestational diabetes. In the Finnish Gestational Diabetes Avoidance Review (RADIEL), the review subjects obtained intensified actual physical physical exercise and dietary counselling for the duration of being pregnant and for the very first year next shipping.

    In this analyze, a polygenic risk rating (PRS) describing the genetic possibility of diabetes was calculated applying gene variants acknowledged to enhance the hazard of variety 2 diabetic issues. The possibility score for form 2 diabetes was linked with elevated glucose concentrations in mid- and late being pregnant as well as just one calendar year immediately after delivery.

    “Gestational diabetic issues as well as prediabetes and diabetic issues a person calendar year following delivery ended up also more prevalent among the people with larger scores,” claims Emilia Huvinen, specialist in obstetrics and gynaecology.

    Qualified steps create much better final results

    The study identified that genetic hazard also impacted the hyperlink in between way of living counselling and gestational diabetic issues as effectively as diabetic issues.

    “Based mostly on our research, intensified life style interventions benefitted only ladies at best genetic possibility of creating kind 2 diabetic issues,” Huvinen confirms.

    In accordance to her, the outcomes are considerable and even globally distinctive.

    “Our examine gives a single probable rationalization for the contradictory benefits of earlier studies investigating the prevention of gestational diabetes until now ,” Huvinen describes.

    In accordance to the researchers, genetic-risk scoring would make it feasible to recognize the expectant mothers most at chance as perfectly as to immediate resources and the most productive preventive steps specially at them. This would be of terrific value in conditions of each constrained societal resources and the well being of these mothers and their children.

    “At the very same time, it can be crucial to realise that, in the case of diabetes, our genetic qualifications does not establish our future. With the aid of a nutritious way of life, you can reverse the effect of a substantial genetic diabetic issues risk,” Huvinen claims, offering encouragement.

    Story Resource:

    Materials offered by University of Helsinki. Take note: Information might be edited for fashion and length.